DynaDes AG

Company founded: April 2013

Dynamic Drug Design deals with the transfer of novel software technology for drug design

At DynaDes, we design pre-clinical drugs using innovative and proven, proprietary computational methods. Combined with our in-house designed compound libraries and synthesis resources, our unique approach is highly efficient in generating novel, exceptionally selective and potent drug candidates.

Milestones / News

Funding Activity 12.09.2012

venture kick stage 2
Funding Activity

venture kick stage 1

DynaDes AG

Emilie Frugier

c/o Department of Biochemistry, University of Zurich, Winterthurerstrasse 190
8057 Zürich

http://www.dynades.com

Contact

Sharing

Links

Support

Awards (1)

A PHILANTHROPIC INITIATIVE OF A PRIVATE CONSORTIUM

Turning scientific innovation into entrepreneurial activity and job creation is the basis of societal and economical prosperity. In the very early stages, startups bear very high risks that are neither carried by public money nor by private investors. Supporting seed stage startups fills a crucial gap and is therefore purely philanthropic.
Read more about the Foundation of Founders